A research report on Cardiac Rhythm Management Devices Market features a succinct analysis on the latest market trends. The report also includes detailed abstracts about statistics, revenue forecasts and market valuation, which additionally highlights its status in the competitive landscape and growth trends accepted by major industry players.. Increase in innovative and advanced technology requirements in healthcare products. Prevalence of cardiac related patients and diseases are some factors driving the market of cardiac Rhythm Management devices market.. Cardiac Rhythm Management Devices are the devices which are made to prevent the unfortunate events with the cardiac patients. However prevalence of heart diseases is increasing day to day, need of prevention to these diseases is increasing and so are the technology standards. Healthcare technology is getting so advance that it came up with cardiac prevention devices to poised heart related issues. Innovation of healthcare is reaching the ...
[49 Pages Report] Check for Discount on Israel Cardiac Rhythm Management Devices Market Outlook to 2022 report by GlobalData. Israel Cardiac Rhythm Management Devices Market Outlook to 2022 Summary...
[49 Pages Report] Check for Discount on Denmark Cardiac Rhythm Management Devices Market Outlook to 2022 report by GlobalData. Denmark Cardiac Rhythm Management Devices Market Outlook to 2022 Summary...
RnRMarketResearch.com adds report "BRIC Cardiac Rhythm Management Market Outlook to 2020" to its store.. "BRIC Cardiac Rhythm Management Market Outlook to 2020″, provides key market data on the BRIC Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.. Inquire For Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=180874 .. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital ...
Have Any Query? Ask Our Expert for Cardiac Rhythm Management Device Market Report @ http://www.360marketupdates.com/enquiry/pre-order-enquiry/10466348. No. of pages in report: 119. Price of Report: $ 3480 (Single User Licence). About 360 Market Updates:. 360 Market Updates is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.. Contact-. Mr. Ameya ...
Cardiac Monitoring & Cardiac Rhythm Management - Global Market Outlook (2016-2022)" Purchase This Report by calling ResearchnReports.com at +1-888-631-6977.. The latest intelligence on the Cardiac Monitoring & Cardiac Rhythm Management market is available in the Global Cardiac Monitoring & Cardiac Rhythm Management Market Research report. This report is a culmination of the key events from last decade to present day, and helps to formulate the best strategy catered to both established market players and new entrants.. A birds eye view of the Cardiac Monitoring & Cardiac Rhythm Management industry made available in the report helps readers to understand the key drivers, restraints, challenges, and opportunities that are shaping the global Cardiac Monitoring & Cardiac Rhythm Management market. Furthermore, the report evaluates challenges experienced from buyers and sellers side. The report offers advice from key industry experts on how these challenges can be overcome.. A major chunk of the ...
Nov. 18, 1969 w. GREATBATCH 3,478,746 CARDIAC IMPLANTABLE DEMAND PACEMAKER Filed May 12, 1965 2 Sheets-Sheet 1 Q l-0IVEIEART BEAT F! G. I INVENTOR. WIL SON GREA TBA TCI-I A 7 TORNE). 2 Sheets-Sheet 2 Filed May 12, 1965 A 7 TOR/VEK United States Patent M 3,478,746 CARDIAC IMPLANTABLE DEMAND PACEMAKER Wilson Greatbatch, Clarence, N.Y., assignor to Medtronic, Inc., Minneapolis, Minn., a corporation of Minnesota Filed May 12, 1965, Ser. No. 455,132 Int. Cl. A61n N36 US. Cl. 128-421 4 Claims ABSTRACT OF THE DISCLOSURE A portable, self-contained, demand cardiac Pacemaker including circuitry which senses each natural heartbeat and resets the Pacemaker pulse generator timing in response to it. The Pacemaker stimulates only skipped beats and does not compete with natural beats, The first generated pulse after a natural beat occurs after a preset time interval slightly longer than the natural interval unless another natural beat has intervened. When a natural beat intervenes, the Pacemaker timer is ...
Cardiac rhythm management refers to a process of monitoring functioning of the heart through devices. Cardiac rhythm management devices are used to provide
Production, means the output of Cardiac Rhythm Management (CRM) Devices Batteries Revenue, means the sales value of Cardiac Rhythm Management (CRM) Devices Batteries This report studies Cardiac Rhythm Management (CRM) Devices Batteries in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, produc
The present invention is directed toward a sensing architecture for use in cardiac rhythm management devices. The sensing architecture of the present invention provides a method and means for certifying detected events by the cardiac rhythm management device. Moreover, by exploiting the enhanced capability to accurately identifying only those sensed events that are desirable, and preventing the use of events marked as suspect, the sensing architecture of the present invention can better discriminate between rhythms appropriate for device therapy and those that are not.
Various aspects of the present subject matter relate to a device. In various embodiments, the device comprises at least one port adapted to connect at least one lead, a CRM functions module connected to the port and adapted to provide at least one CRM function using the lead, a neural function module, and a controller connected to the CRM functions module and the neural function module. The at least one CRM function includes a function to provide an electrical signal to the lead to capture cardiac tissue. The neural function module includes a signal processing module connected to the port and adapted to receive and process a nerve traffic signal from the lead into a signal indicative of the nerve traffic. The controller is adapted to implement a CRM therapy based on the signal indicative of the nerve traffic. Other aspects are provided herein.
Aims We investigated the applicability of the Ventricular Capture Control (VCC) and Atrial Capture Control (ACC) algorithms for automatic management of cardiac stimulation featured by Biotronik pacemakers in a broad, unselected population of pacemaker recipients. Methods and results Ventricular Capture Control and Atrial Capture Control were programmed to work at a maximum adapted output voltage as 4.8 V in consecutive recipients of Biotronik pacemakers. Ambulatory threshold measurements were made 1 and 12 months after pacemaker implant/replacement in all possible pacing/sensing configurations, and were compared with manual measurements. Among 542 patients aged 80 (73-85) years, 382 had a pacemaker implant and 160 a pacemaker replacement. Ventricular Capture Control could work at long term in 97% of patients irrespectively of pacing indication, lead type, and lead service life, performance being superior with discordant pacing/sensing configurations. Atrial Capture Control could work in 93% of ...
Cardiac rhythm management devices are commonly used for the treatment of arrhythmias specifically superventricular arrhythmias (SVA) and ventricular arrhythmias (VA) and heart failure.
... Cardiac Rhythm Management Market Analysis, Size, Trends - Europe - 2019-2025 - - Market research report and industry analysis - 12771961
A 77-year-old woman, with an otherwise good clinical status, was admitted to the hospital for syncope. An electrocardiogram (ECG) revealed second-degree atrioventricular block with good ventricular response. Twelve hours later, she experienced a second episode of syncope and the ECG revealed atrioventricular block with pauses ,3seconds; she underwent placement of a temporary pacemaker (TP) after cannulation of right subclavian vein and insertion of a lead that appeared to pace right ventricle. An X-ray showed the TP lead following the outer curvature of the heart to the apex (Figure A). An intracardiac ECG recorded complexes compatible with right ventricular epicardial pacing (Figure B). Intracardiac ECG is a recording of the patients electrical activity that uses TP leads (proximal V1 and distal V2). Thus, the patients own rhythm must be conserved and he or she must not be completely dependent on the pacemaker. Negative QRS deflection indicates an endocardial site; positive-negative ...
A heart pacemaker system has an electrode line with a proximal end which is introduced into a connector of the pacemaker housing, and a distal end having an electrode head attachable to the heart of a user. One or more of the distal or proximal ends of the electrode line, the connector, or a region of the electrode line are provided with a component consisting of shape-memory metal. These components have a first shape at temperatures different from body temperature, and assume a second shape when at body temperature. The shape-memory metal component, if disposed at the proximal end of the electrode line or at the connector, is arrnaged to provide a firm mechanical and electrical connection of the electrode line with the pacemaker housing upon the change of shape of the component. The shape-memory metal component, if disposed at the distal end, is arranged to assist in providing, either directly or indirectly, a reliable, mechanical and electrical connection of the electrode line to the heart upon the
A cardiac rhythm management device includes a dual chamber pacemaker especially designed for treating congestive heart failure. The device incorporates a programmed microcontroller which is operative to adjust the pacing mode-AV delay of the pacemaker so as to achieve optimum hemodynamic performance. Atrial cycle lengths measured during transient (immediate) time intervals following a change in the mode-AV delay are signal processed and a determination can then be made as to which particular configuration yields optimum performance.
Patient Temperature Management Devices Market report focuses on the major drivers and restraints for the key players. It also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Patient Temperature Management Devices Industry research report is a professional and in-depth study on the current state of the Patient Temperature Management Devices Industry.
A dual chamber pacemaker and method for ventricular rate smoothing during high rate episodes such as atrial fibrillation are provided. The pacemaker determines when there is a pathologically high atrial rate episode, such as by determining when atrial senses correspond to a spontaneous atrial rate above a predetermined upper rate limit. When such an episode is determined, the pacemaker determines a ventricular pacing escape interval, corresponding to a flywheel rate, the flywheel rate being set at the beginning of the episode to substantially equal the atrial rate just before the high rate episode. As long as the episode continues, the flywheel rate is incremented upward whenever a ventricular sense occurs, thereby following the average ventricular rate; whenever the flywheel escape interval times out and a ventricular pace is delivered, the flywheel rate is decremented. By allowing ventricular senses and pacing only after timeout of an escape interval which substantially equals average ventricular rate
Name: Dr Munmohan Virdee, specialty: Cardiology , subspecialty: Cardiac devices ,Devices: cardiac resynchronisation therapy device (CRT) ,Devices: dual chamber pacemaker insertion ,Devices: implantable cardioverter defibrillator (ICD) ,Devices: single chamber pacemaker insertion ,Electrophysiology ,Electrophysiology complex cardiac ablation ,Electrophysiology intervention ,Electrophysiology simple cardiac ablation
A cardiac rhythm management system detects edema. In response to an episode of detected edema, it initiates or adjusts a cardiac resynchronization therapy and/or a cardiac contractility modulation (CCM) therapy.
Old people are prone to heart diseases. As such, the expanding base of geriatric populationis foreseento bolster the growth for global implantable cardiac rhythm management device market
Anesthesia & Analgesia: November 2016 - Volume 123 - Issue 5 - p 1143-1148. AUTHORS: Williams, Matthew R. MD et al. BACKGROUND: Radiofrequency identification (RFID) detection systems are used to detect retained surgical sponges and may cause electromagnetic interference (EMI), altering intended function of cardiac pacing systems. Three pediatric patients requiring temporary pacing for postoperative atrioventricular block experienced transient inhibition of ventricular pacing during the use of RFID detection system. Bench testing was performed to evaluate the mechanism of pacemaker inhibition.. METHODS: Impedance of temporary pacing wires was obtained using a pacing system analyzer. Temporary pacemakers (Medtronic 5388, Medtronic 5392, and Biotronik Reocor D) at nominal settings (VVI 120 bpm, output 10 mA) were attached at the ventricular terminal to temporary pacing wires and a resistor for sham impedance in physiologic range. An RFID detection system and wand (RF Assure, model 200) or mat was ...
GlobalDatas new report, "EU5 Cardiac Rhythm Management Market Outlook to 2020", provides key market data on the EU5 Cardiac Rhythm Management Market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Cardiac Resynchronisation Therapy (Defibrillators and Pacemakers), Implantable Cardioverter Defibrillators, Implantable Loop Recorders and Pacemakers.. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Cardiac Rhythm Management Market wherever available.. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.. The ...
Global CRM Devices Batteries Market: Overview Irregular heartbeats, also known as arrhythmias, are often treated using cardiac rhythm management (CRM) devices. CRM devices are powered by batteries that help in regularizing heart beats in a regular rhythm. Currently, batteries, especially lithium anode batteries with different cathode chemistry, are used for powering CRM devices. The growing…
Name: Dr John Foran, specialty: Cardiology ,General (internal) medicine , subspecialty: Cardiac MRI ,Coronary angiography ,Devices: cardiac resynchronisation therapy device (CRT) ,Devices: dual chamber pacemaker insertion ,Devices: implantable cardioverter defibrillator (ICD) ,Devices: single chamber pacemaker insertion ,Echo/imaging ,Electrophysiology ,Electrophysiology complex cardiac ablation ,Electrophysiology intervention ,Electrophysiology simple cardiac ablation ,Fractional flow reserve (FFR) ,Interventional cardiology ,Percutaneous coronary intervention with/without stenting ,Reporting of echocardiography ,Stress echocardiography ,Stroke medicine ,Trans-oesophageal echocardiography ,Transthoracic echocardiography
In 2010, the European market for cardiac rhythm management, electrophysiology, and ablation devices was valued at over €2.3 billion ($3.09 billion).
Netherlands Cardiovascular Devices Market Outlook to 2022 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others is a market research report available at US $5995 for a Single User PDF License from RnR Market Research Reports Library.
The Report Denmark Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology, Prosthetic Heart Valves and Others provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz
ICD-10-PCS. PACEMAKERS. Insertion or Replacement of Other (RA and RV) Lead. 37.71. Initial insertion of transvenous lead (electrode) into ventricle. ICD-9-CM. ICD-10-PCS. Implantation or Replacement of CRT-P Generator Only. 00.53. Implantation or replacement of cardiac resynchronization pacemaker, pulse 2015 procedure code crosswalk: icd-9-cm to icd-10-pcs - Medtronic Further inquiries on pacing at the bundle of His should be referred to Medtronic CRHF Office of Medical Affairs. Background pacemaker with transvenous electrode(s); atrial. Because the The ICD-10-PCS procedure coding would include both a generator insertion code and the appropriate number of codes for insertion pacing at the bundle of his - Medtronic ICD-9-CM. ICD-10-CM/PCS. 37.87. Replacement of any type pacemaker device with dual-chamber device. 0JH606Z. Insertion of pacemaker, single chamber into chest Replacement of transvenous atrial and/or ventricular lead(s). (electrode). 02H63JZ. Insertion of pacemaker lead into right ...
TY - JOUR. T1 - Echocardiographic localization of an inadvertently placed pacing catheter in the left ventricle. AU - Loungani, R. R.. AU - Wanat, F. E.. AU - Nanda, N. C.. AU - Finch, A.. PY - 1993/1/1. Y1 - 1993/1/1. N2 - This report describes a patient in whom a permanent transvenous pacemaker lead was placed unintentionally across the atrial septum and retained in the left ventricle for nearly 11 years before the error was recognized. A 12- lead electrocardiogram showed paced complexes with right bundle branch block configuration. This appearance raised suspicion that the pacemaker electrode might be in the left ventricle and this was confirmed by two-dimensional echocardiography. Two-dimensional echocardiography is useful for the diagnosis of pacing lead malplacement and should be performed in any patient who develops right bundle branch block pattern on the surface electrocardiogram following pacemaker implantation.. AB - This report describes a patient in whom a permanent transvenous ...
Pacemaker implantation complication rates in elderly and young patients Kazim Serhan Özcan, Damirbek Osmonov, Servet Altay, Cevdet Dönmez, Ersin Yildirim, Ceyhan Türkkan, Baris Güngör, Ahmet Ekmekçi, Ahmet Taha Alper, Kadir Gürkan, Ä°zzet ErdinlerDepartment of Cardiology, Siyami Ersek Cardiovascular and Thoracic Surgery Center, Istanbul, TurkeyAims: To evaluate the complication rate differences between elderly and younger patients who receive a permanent pacemaker implantation.Methods: We reviewed all cases admitted to our institution between January 2008 and June 2009 with symptomatic bradyarrhythmia for whom a permanent pacemaker was implanted. Beginning in June 2009, we prospectively collected data from all patients with the same diagnosis and procedure. The frequency of complications due to the pacemaker implantation procedure was evaluated and compared between young (<70 years old) and elderly (≥70 years old) patients.Results: Among 574 patients with a
Abbott recieved CE mark approval for Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) in EU.
Broadway star Nick Corderos doctors gave the former Blue Bloods actor a temporary pacemaker due to an irregular heart rate while he fights COVID-19, the respiratory illness caused by the coronavirus. Corderos wife, Amanda Kloots, shared the update in her Instagram Story Friday, assuring fans the [...]
QRS axis -60 Interpretation: Sinus rhythm sensed by a dual chamber pacemaker with ventricular capture. A-V interval 0.19 sec. Normal pacemaker function (atrial sensing, ventricular pacing). The patient complained of dizziness and lightheadedness. Her electrocardigram showed second degree A-V block Mobitz type II, left anterior fascicular block and right bundle branch block. Dual chamber pacemaker (DDDR) has been implanted with resolution of symptoms. << back to ECG Decoder ...
Early buyers will receive 10% customization on reports.. The nanotechnology-based medical devices market witnessed healthy growth during the last decade primarily attributed to the rising aging population and increasing government support, globally. However, high costs and time-consuming product approval processes of the nanotechnology-based medical devices are inhibiting the growth of this market to a certain extent.. In this report, the nanotechnology-based medical devices market is divided on the basis of products, applications, and regions. On the basis of products, the market is categorized into biochips, implantable materials, medical textile and wound dressing, active implantable devices, and others. The implantable materials segment is bifurcated into dental filling materials and bone restorative materials; while the active implantable devices segment is bifurcated into cardiac rhythm management devices, hearing aid devices, and retinal implants. On the basis of applications, the ...
... definition at Dictionary.com, a free online dictionary with pronunciation, synonyms and translation. Look it up now!
The recognition of proper and improper function of implanted electronic pacemakers utilized for cardiac stimulation may be aided by a knowledge of how they function and their effect on the electrocardiographic tracing. The electrocardiograms of patients with fixed rate, demand, atrial synchronous, and ventricular synchronous pacemakers are described. Pacemaker malfunction may arise at a number of points within the pacemaker itself or from failure of the electrical impulse to be conducted to the myocardium. Careful analysis of the electrocardiographic patterns may permit an accurate diagnosis of pacemaker malfunction even before symptoms develop. Electrocardiographic examples are analyzed and discussed. ...
According to a new report Global Clot Management Devices Market, published by KBV Research, the global Clot Management Devices is expected to attain a market size of $1.7billion by 2022
Summary GlobalData s new report, Belgium Clot Management Devices Market Outlook to 2022, provides key market data on the Belgium Clot Management Devices
China Clot Management Devices Market Outlook to 2021BriefGlobalDatas additional report, China Clot Management Devices Market Outlook to 2021, offers crucial market ...
An implantable pacemaker effectuates a capture verification method that minimizes the expenditure of battery current. A capture verification test is performed only occasionally, on a sampled basis, following delivery of a stimulation pulse. If capture is not verified, a loss of capture response mode is invoked that searches for an appropriate capture threshold, and when found, sets the stimulation energy at a level that is a prescribed safety factor above the capture threshold. All testing for capture is performed only after the heart rhythm has been measured, a short test pacing interval is selected that will be likely to overdrive the native rhythm, and the test pacing pulse delivered is delivered at the shortened interval so that the likelihood of fusion will be minimal.
Our physician performed a left heart cath 93458 same day as a Temporary Pacemaker Placement 33210 and Arterial Line 36140. According to the NCCI edit,
This study investigates the influence of implantation depth and prosthesis oversizing on conduction abnormalities and permanent pacemaker implantation after SAPIEN 3 implantation
QRS axis 80 Interpretation: Abnormal ECG. Sinus rhythm with frequent unifocal PVCs. First degree AV block. Borderline left atrial abnormality. Left axis deviation. Left anterior fascicular block. Right bundle branch block with secondary repolarization abnormalities. Possible left ventricular hypertrophy. The ECG documents trifascicular block. In ER the patient had periods of high degree AV block (several non-conducted P waves). He underwent permanent pacemaker implantation (VVIR) with active fixation lead. Few positions of the lead in the RV were explored before satisfactory capture was found probably because of presence of scar for previous myocardial infarction. << back to ECG Decoder ...
Prior ICD and/or pacemaker placement where study imaging site has not been trained and certified specifically for this protocol to conduct cardiac MRI in subjects with ICD and/or pacemaker placement.. a. Presence of a pacemaker and/or ICD generator with any of the following limitations/conditions are excluded: i. Manufactured before the year 2000, ii. Leads implanted , 6 weeks prior to signing informed consent, iii. Non-transvenous epicardial, abandoned, or no-fixation leads, iv. Subcutaneous ICDs, v. Leadless pacemakers, vi. Any other condition that, in the judgement of device-trained staff, would deem an MRI contraindicated.. b. Pacemaker dependence with an ICD (Note: pacemaker-dependent candidates without an ICD are not excluded).. c. A cardiac resynchronization therapy (CRT) device implanted , 3 months prior to signing informed consent.. ...
MARKET SCOPE. The "Global Cardiovascular Implants Market Analysis to 2027" is a specialized and in-depth study of the medical device with a special focus on the global market trend analysis. The report aims to provide an overview of cardiovascular implants market with detailed market segmentation by product, application and geography. The global cardiovascular implants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cardiovascular implants market players and offers key trends and opportunities in the market.. Market segmentation:. Cardiovascular Implants Market to 2027 - Global Analysis and Forecasts by Product (Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Rhythm Management Devices); Application (Congestive Heart Failure, Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Others) and Geography. By Geography North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) ...
A method of presenting information for evaluating the condition of chronically impaired cardiac patients based on long-term assessment of activity trends, using a memoried implanted cardiac rhythm management device having a plurality of programmable parameters and one or more sensors for sensing one or more parameters related to an activity level of the patient. The method includes acquiring sensor signal data indicative of the activity level of the patient, accumulating sensor signal data in memory and using the accumulated sensor signal data to determine the activity level of the patient during a predetermined period of time, recording the activity level during a plurality of sequential time periods, adding contemporary annotation information to the activity data and producing a data record of the activity level with the annotation information during sequential time periods sufficient to indicate trends in a patients activity level.
MEDICINA is a peer reviewed monthly scientific journal of Lithuanian Medical Association, Lithuanian University of Health Sciences and Vilnius University which is indexed and abstracted in Thomson Reuters Science Citation Index Expanded (SciSearch®), Journal Citation Reports/Science Edition, MEDLINE, Index Copernicus and Directory of Open Access Journals (DOAJ).
TY - JOUR. T1 - I can hear it, but where is it coming from? A case of iatrogenic arteriovenous fistula after pacemaker lead extraction.. AU - Ong, Kevin C.. AU - Asirvatham, Samuel J. AU - Rihal, Charanjit. AU - Hagler, Donald J.. AU - Pislaru, Sorin V.. PY - 2013/12. Y1 - 2013/12. UR - http://www.scopus.com/inward/record.url?scp=84904217297&partnerID=8YFLogxK. UR - http://www.scopus.com/inward/citedby.url?scp=84904217297&partnerID=8YFLogxK. M3 - Article. C2 - 23825016. AN - SCOPUS:84904217297. VL - 14. SP - 1202. JO - European Heart Journal Cardiovascular Imaging. JF - European Heart Journal Cardiovascular Imaging. SN - 2047-2404. IS - 12. ER - ...